We found the challenges for implementation of "molecular autopsy" for sudden cardiac death cases in Japan.
By Kanako Koike @kanakokoike_78
https://t.co/rIHvVBKcQp
#circ_j https://t.co/A6TDCxM9Bx
The first Japanese clinical report of HM3. Excellent survival was demonstrated and HM3 was superior in terms of rehospitalization. Notably, LVAD-related thrombotic events have almost disappeared.
By Koichi Inoue
https://t.co/KYyE5BGRpT
#circ_j https://t.co/G7nMBu6BeX